What: Oncothyreon is down 30% at 1:30 p.m. EST after announcing updated data from its ongoing trials testing ONT-380 in patients with breast cancer yesterday. So what: From the stock move, you'd think ...
While myriad attempts to pass federal privacy legislation have all fizzled out in recent years, House Energy and Commerce Committee Chairwoman Cathy McMorris Rodgers (R-WA) and Senate Commerce ...